103 related articles for article (PubMed ID: 38739840)
1. Discovery of Oral AMP-Activated Protein Kinase Activators for Treating Hyperlipidemia.
Wang M; Han Z; Fan B; Qu K; Zhang W; Li W; Li J; Li L; Li J; Li H; Wu S; Wang D; Zhu H
J Med Chem; 2024 May; 67(10):7870-7890. PubMed ID: 38739840
[TBL] [Abstract][Full Text] [Related]
2. AMPK activator C24 inhibits hepatic lipogenesis and ameliorates dyslipidemia in HFHC diet-induced animal models.
Sun SM; Xie ZF; Zhang YM; Zhang XW; Zhou CD; Yin JP; Yu YY; Cui SC; Jiang HW; Li TT; Li J; Nan FJ; Li JY
Acta Pharmacol Sin; 2021 Apr; 42(4):585-592. PubMed ID: 32724176
[TBL] [Abstract][Full Text] [Related]
3. Daming capsule, a hypolipidaemic drug, lowers blood lipids by activating the AMPK signalling pathway.
Bian Y; Li X; Li X; Ju J; Liang H; Hu X; Dong L; Wang N; Li J; Zhang Y; Yang B
Biomed Pharmacother; 2019 Sep; 117():109176. PubMed ID: 31387185
[TBL] [Abstract][Full Text] [Related]
4. Cordycepin activates AMP-activated protein kinase (AMPK) via interaction with the γ1 subunit.
Wu C; Guo Y; Su Y; Zhang X; Luan H; Zhang X; Zhu H; He H; Wang X; Sun G; Sun X; Guo P; Zhu P
J Cell Mol Med; 2014 Feb; 18(2):293-304. PubMed ID: 24286368
[TBL] [Abstract][Full Text] [Related]
5. Cordycepin prevents hyperlipidemia in hamsters fed a high-fat diet via activation of AMP-activated protein kinase.
Guo P; Kai Q; Gao J; Lian ZQ; Wu CM; Wu CA; Zhu HB
J Pharmacol Sci; 2010; 113(4):395-403. PubMed ID: 20724804
[TBL] [Abstract][Full Text] [Related]
6. Kanglexin, a new anthraquinone compound, attenuates lipid accumulation by activating the AMPK/SREBP-2/PCSK9/LDLR signalling pathway.
Li X; Hu X; Pan T; Dong L; Ding L; Wang Z; Song R; Wang X; Wang N; Zhang Y; Wang J; Yang B
Biomed Pharmacother; 2021 Jan; 133():110802. PubMed ID: 33202286
[TBL] [Abstract][Full Text] [Related]
7. The adenosine derivative 2',3',5'-tri-O-acetyl-N6-(3-hydroxylaniline) adenosine activates AMPK and regulates lipid metabolism in vitro and in vivo.
Guo P; Lian ZQ; Sheng LH; Wu CM; Gao J; Li J; Wang Y; Guo YS; Zhu HB
Life Sci; 2012 Jan; 90(1-2):1-7. PubMed ID: 21939670
[TBL] [Abstract][Full Text] [Related]
8. ε-Viniferin, a promising natural oligostilbene, ameliorates hyperglycemia and hyperlipidemia by activating AMPK
Liu R; Zhang Y; Yao X; Wu Q; Wei M; Yan Z
Food Funct; 2020 Nov; 11(11):10084-10093. PubMed ID: 33140813
[TBL] [Abstract][Full Text] [Related]
9. Magnolol Alleviates Inflammatory Responses and Lipid Accumulation by AMP-Activated Protein Kinase-Dependent Peroxisome Proliferator-Activated Receptor α Activation.
Tian Y; Feng H; Han L; Wu L; Lv H; Shen B; Li Z; Zhang Q; Liu G
Front Immunol; 2018; 9():147. PubMed ID: 29467759
[TBL] [Abstract][Full Text] [Related]
10. Cooked rice prevents hyperlipidemia in hamsters fed a high-fat/cholesterol diet by the regulation of the expression of hepatic genes involved in lipid metabolism.
Choi WH; Gwon SY; Ahn J; Jung CH; Ha TY
Nutr Res; 2013 Jul; 33(7):572-9. PubMed ID: 23827132
[TBL] [Abstract][Full Text] [Related]
11. A novel AMPK activator, WS070117, improves lipid metabolism discords in hamsters and HepG2 cells.
Lian Z; Li Y; Gao J; Qu K; Li J; Hao L; Wu S; Zhu H
Lipids Health Dis; 2011 Apr; 10():67. PubMed ID: 21529359
[TBL] [Abstract][Full Text] [Related]
12. Ergostatrien-3β-ol from Antrodia camphorata inhibits diabetes and hyperlipidemia in high-fat-diet treated mice via regulation of hepatic related genes, glucose transporter 4, and AMP-activated protein kinase phosphorylation.
Kuo YH; Lin CH; Shih CC
J Agric Food Chem; 2015 Mar; 63(9):2479-89. PubMed ID: 25693659
[TBL] [Abstract][Full Text] [Related]
13. HVC1 ameliorates hyperlipidemia and inflammation in LDLR
Cheon SY; Chung KS; Lee KJ; Choi HY; Ham IH; Jung DH; Cha YY; An HJ
BMC Complement Altern Med; 2017 Apr; 17(1):222. PubMed ID: 28427397
[TBL] [Abstract][Full Text] [Related]
14. [Difference of lipid-lowering efficacy of "Xinjianqu" before and after fermentation and its mechanism based on LKB1-AMPK pathway and 16S rDNA sequencing technology].
Li DH; Wang RS; Zhang ZL; Zhu JG; Sun MM; Qiao J
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(8):2146-2159. PubMed ID: 37282903
[TBL] [Abstract][Full Text] [Related]
15. Structural simplification and bioisostere principle lead to Bis-benzodioxole-fibrate derivatives as potential hypolipidemic and hepatoprotective agents.
Xie Y; Liu J; Shi Y; Wang B; Wang X; Wang W; Sun M; Xu X; Cheng L; He S
Bioorg Chem; 2021 Dec; 117():105454. PubMed ID: 34740054
[TBL] [Abstract][Full Text] [Related]
16. [The hypolipidemic and liver protective effect of (Z)-N-(2-hydroxyethyl) docos-13-enamide on hyperlipidemic golden hamsters].
Shen YH; Jin X; Zhao Y; Altunbak G; Lin LM; Shu P; Wei X
Yao Xue Xue Bao; 2012 Sep; 47(9):1252-6. PubMed ID: 23227559
[TBL] [Abstract][Full Text] [Related]
17.
Cao K; Lv W; Liu X; Fan Y; Wang K; Feng Z; Liu J; Zang W; Xing L; Liu J
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31936037
[TBL] [Abstract][Full Text] [Related]
18. Hypolipidemic effect of pure total flavonoids from peel of Citrus (PTFC) on hamsters of hyperlipidemia and its potential mechanism.
Ling Y; Shi Z; Yang X; Cai Z; Wang L; Wu X; Ye A; Jiang J
Exp Gerontol; 2020 Feb; 130():110786. PubMed ID: 31760082
[TBL] [Abstract][Full Text] [Related]
19. Discovery and translation of a target engagement marker for AMP-activated protein kinase (AMPK).
Grempler R; Wolff M; Simon E; Schmid R; Eisele C; Rieber K; Fischer E; Mettel S; Gabrielyan O; Delic D; Luippold G; Redeman N
PLoS One; 2018; 13(5):e0197849. PubMed ID: 29799853
[TBL] [Abstract][Full Text] [Related]
20. The hypotensive effect of acute and chronic AMP-activated protein kinase activation in normal and hyperlipidemic mice.
Greig FH; Ewart MA; McNaughton E; Cooney J; Spickett CM; Kennedy S
Vascul Pharmacol; 2015 Nov; 74():93-102. PubMed ID: 26196300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
